The key enzymes of NAD+, such as de novo synthesis-nicotinate phosphoribosyltransferase and salvage synthesis-nicotinamide phosphoribosyl-transferase, are overexpressed in various cancers and contribute to higher glycolytic activity, cancer progression, chemoresistance, and poor prognosis [94-97]. The gene discussed is NAMPT; the disease is cancer.